DRUG SUBSTITUTION

被引：6
|
作者：
STOFFER, SS
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1979年 / 242卷 / 12期
关键词：
D O I：
10.1001/jama.1979.03300120011004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1257 / 1257
页数：1
相关论文
共 50 条
  • [31] GENERIC DRUG SUBSTITUTION AND THE FDA LIST OF APPROVED DRUG PRODUCTS
    RUGGIERI, NL
    FOOD AND DRUG LAW JOURNAL, 1981, 36 (11): : 556 - 564
  • [32] "Hybrid drug", a new category of drug, a new right of substitution for the pharmacist
    Guerriaud, Mathieu
    ACTUALITES PHARMACEUTIQUES, 2019, 58 (584): : 9 - 9
  • [33] Drug use and opioid substitution treatment for prisoners
    Heino Stöver
    Ingo Ilja Michels
    Harm Reduction Journal, 7
  • [34] DRUG SUBSTITUTION - REMEDY OR RIP-OFF
    GOODMAN, WE
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1983, 128 (02) : 198 - &
  • [35] Therapeutic drug monitoring in the opioid substitution treatment
    Kuzin, M.
    PHARMACOPSYCHIATRY, 2024, 57 (02) : 88 - 89
  • [36] Influence of generic substitution on drug sales pattern
    Andersson, Karolina
    Petzold, Max G.
    Allebeck, Peter
    Carlsten, Anders
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S210 - S211
  • [37] Determinants of Generic Drug Substitution in the United States
    Segal, Jodi B.
    Onasanya, Oluwadamilola
    Daubresse, Matthew
    Lee, Chia-Ying
    Moechtar, Mischka
    Pu, Xia
    Dutcher, Sarah K.
    Romanelli, Robert J.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (01) : 151 - 157
  • [38] Biographical data of patients in drug substitution programmes
    Toenies, Hans
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2012, 162 (1-2) : 39 - 43
  • [39] Effectiveness, safety and cost of drug substitution in hypertension
    Johnston, Atholl
    Stafylas, Panagiotis
    Stergiou, George S.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (03) : 320 - 334
  • [40] Determinants of Generic Drug Substitution in the United States
    Jodi B. Segal
    Oluwadamilola Onasanya
    Matthew Daubresse
    Chia-Ying Lee
    Mischka Moechtar
    Xia Pu
    Sarah K. Dutcher
    Robert J. Romanelli
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 151 - 157
12345